Personalized treatment strategies have advanced lung cancer brain metastases management, integrating targeted therapies and immunotherapies for improved outcomes.
Stereotactic radiosurgery and whole-brain radiation therapy are evolving with novel systemic therapies, maintaining crucial roles in treatment.
Multidisciplinary approaches optimize treatment plans by considering genetic mutations, patient performance status, and potential side effects.
Ongoing research aims to refine strategies, focusing on improved survival and quality of life for patients with lung cancer brain metastases.
SHOW MORE
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.